Rapid resistance to vemurafenib – a treatment for a type of advanced melanoma, the deadliest form of skin cancer – could be prevented by blocking a druggable family of proteins, according to research. Scientists have revealed the MLK family of four enzymes 'undoes' the tumour-shrinking effects of vemurafenib.

More...